文献速递免疫规划卫生政策与健康促进

使用国家免疫技术咨询小组成熟度评估工具对世界卫生组织东地中海区域国家免疫技术咨询小组的区域范围评估——2023年经验

Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) - Experience from the Eastern Mediterranean Region of the World Health Organization, 2023.
PubMed 文献 · Vaccine · 2024-02-26

2023年,世界卫生组织东地中海区域22个国家的国家免疫技术咨询小组主席和秘书处参加线上培训,使用国家免疫技术咨询小组成熟度评估工具自评并制定改进计划。20个国家提交评估结果,19个提交改进计划;各指标满足标准比例从独立性与非偏倚的36%到建立与构成的74%不等,独立性与非偏倚领域成熟度最低。

要点

  • 20个国家中仅1个(5%)在独立性与非偏倚指标达到中等或更高成熟度。
  • 建立与构成及融入政策制定流程两项指标各有11个(55%)国家达中等或更高成熟度。
  • 参与者认为该工具简洁、有用、易用,利益冲突防控是区域最需改进领域。

核心结论

  • 国家免疫技术咨询小组成熟度评估工具是实用工具,可为各国和区域提供洞察与战略方向。
  • 利益冲突的预防与管理是东地中海区域最需要改进的领域。
  • 计划开展的活动应予以实施、监测,并于2025年进行后续评估。

研究设计与样本

  • 2023年东地中海区域22个国家的国家免疫技术咨询小组主席和秘书处参加线上成熟度评估工具培训。
  • 参与者使用该工具自评本组并制定改进计划,算法利用数据确定七个指标的成熟度水平。
  • 结果按收入组进行区域汇总。

主要发现

  • 22个国家(或国家免疫技术咨询小组)中,20个(91%)提交评估结果,19个提交改进计划。
  • 各指标满足标准比例从独立性与非偏倚的36%到建立与构成的74%不等。
  • 20个国家免疫技术咨询小组中,独立性与非偏倚指标达中等或更高成熟度的有1个(5%)。
  • 运营指标达中等或更高成熟度的有3个(15%),提出建议指标有4个(20%),利益相关方认可指标有6个(30%),资源与秘书处支持指标有7个(35%)。
  • 建立与构成指标及融入政策制定流程指标各有11个(55%)国家免疫技术咨询小组达中等或更高成熟度。

关键数值与推荐

  • 各指标满足标准比例:独立性与非偏倚36%,建立与构成74%。
  • 20个国家免疫技术咨询小组中各指标达中等或更高成熟度的数量:独立性与非偏倚1个(5%),运营3个(15%),提出建议4个(20%),利益相关方认可6个(30%),资源与秘书处支持7个(35%),建立与构成11个(55%),融入政策制定流程11个(55%)。

临床怎么用

  • 原文结论指出该工具可为各国和区域提供洞察与战略方向。
  • 原文结论指出利益冲突的预防与管理是东地中海区域最需改进的领域。
  • 原文建议计划开展的活动应予以实施、监测,并于2025年进行后续评估。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

National Immunization Technical Advisory Groups (NITAGs) are independent bodies that help improve national immunization programmes in decision making on immunization policy. The new NITAG Maturity Assessment Tool (NMAT) provided an opportunity to conduct a region-wide assessment to improve NITAG capacity and foster institutional growth. We share experience of the Eastern Mediterranean Region (EMR) of the World Health Organization (WHO) in using NMAT and the use of findings to develop improvement plans. NITAG chairs and secretariats from 22 EMR countries attended a virtual NMAT training in 2023. They self-assessed their NITAGs using the tool and developed improvement plans. An algorithm used the data to determine maturity levels for seven indicators. We consolidated results for the region by income groups. Of 22 countries (or NITAGs), 20 (91%) submitted NITAG assessment findings and 19 an improvement plan. The proportion of criteria met per indicator varied from 36% for independence and non-bias to 74% for establishment and composition. Maturity level varied by indicator. Of 20 NITAGs, less than half had an intermediate or higher-level maturity for the indicators of independence and non-bias 1 (5%), operations 3 (15%), making recommendations 4 (20%), stakeholder recognition 6 (30%), and resources and secretariat support 7 (35%). Meanwhile 11 (55%) NITAGs had an intermediate or higher maturity level for the indicators of establishment and composition and for integration into policy making process. Participants described NMAT as a concise, useful, user-friendly tool. NMAT is a practical tool that can be used by NITAGs to provide insights and strategic direction for individual countries and regionally. Prevention and management of conflict of interest is the domain that requires the most improvement in EMR. Planned activities should be implemented, monitored and a follow up assessment conducted in 2025.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Sume GE, Hasan Q, Shefer A, et al. Region-wide assessment of National Immunization Technical Advisory Groups (NITAGs) using the NITAG Maturity Assessment Tool (NMAT) - Experience from the Eastern Mediterranean Region of the World Health Organization, 2023. Vaccine. 2024. PMID: 38413276. doi:10.1016/j.vaccine.2024.02.058

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。